Lidia Mak

发表

Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.

H. Shmeeda, D. Tzemach, L. Mak, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models

H. Shmeeda, Y. Amitay, J. Gorin, 2010, Cancer Chemotherapy and Pharmacology.

Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models

D. Tzemach, A. Gabizon, Alberto Gabizon, 2002, Journal of drug targeting.

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors

H. Shmeeda, D. Tzemach, A. Gabizon, 2006, Molecular Cancer Therapeutics.

Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues

H. Shmeeda, Y. Amitay, D. Tzemach, 2016, Pharmaceutical Research.

Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy

H. Shmeeda, Y. Amitay, D. Tzemach, 2020, Cancer drug resistance.

Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues

H. Shmeeda, Y. Amitay, D. Tzemach, 2015, Pharmaceutical Research.

Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.

H. Shmeeda, Y. Amitay, J. Gorin, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer

Y. Barenholz, H. Shmeeda, Y. Amitay, 2016, Journal of drug targeting.

Folate receptor targeting of pegylated liposomal cisplatin enhances anti-tumor activity in mouse models without increasing toxicity

D. Tzemach, A. Gabizon, S. Zalipsky, 2002 .

Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.

H. Shmeeda, Y. Amitay, D. Tzemach, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.

H. Shmeeda, D. Tzemach, A. Gabizon, 2009, Journal of controlled release : official journal of the Controlled Release Society.